BA/BE (Bioavailability/Bioequivalence) services are scientific studies conducted to evaluate the equivalence of generic and branded pharmaceutical products. These studies analyze the rate and extent to which a drug is absorbed by the body, ensuring that generic versions perform similarly to the original product in terms of safety and effectiveness.Read more
Clinical Development Services
Clinical development services encompass the comprehensive range of activities involved in bringing a new drug or medical treatment from initial concept to market approval. These services include protocol development, patient recruitment, data collection and analysis, regulatory compliance, and clinical trial management, ensuring the safety and efficacy of the treatment.Read more
Biologics are complex therapeutic products derived from living organisms, such as proteins, antibodies, and vaccines, which are used to treat various diseases. Biosimilars, on the other hand, are highly similar versions of approved biologics that have demonstrated comparable efficacy, safety, and quality to the reference product.
We provide services for Biologics and Biosimilars, which include the development, Analysis through characterization, pre-clinical comparability, clinical comparability and regulatory support for biologic drugs and their biosimilar counterparts.Read more